Source: European Medicines Agency (EU) Revision Year: 2018 Publisher: Sanofi-Aventis Deutschland GmbH, D-65926, Frankfurt am Main, Germany
Arava 10 mg film-coated tablets.
Pharmaceutical Form |
---|
Film-coated tablet. White to almost white, round film-coated tablet, imprinted with ZBN on one side. |
Each tablet contains 10 mg of leflunomide.
Excipients with known effect: Each tablet contains 78 mg of lactose monohydrate.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Leflunomide |
Leflunomide is a disease-modifying anti-rheumatic agent with antiproliferative properties. A771726, the active metabolite of leflunomide, inhibits the human enzyme dihydroorotate dehydrogenase (DHODH) and exhibits antiproliferative activity. |
List of Excipients |
---|
Tablet core: Maize starch Film-coating: Talc (E553b) |
Blister: Aluminium/Aluminium blister. Pack sizes: 30 and 100 film-coated tablets.
Bottle: 100 ml HDPE-wide-necked bottle, with screw cap with integrated desiccant container, containing either 30 or 100 film-coated tablets.
Not all pack sizes may be marketed.
Sanofi-Aventis Deutschland GmbH, D-65926, Frankfurt am Main, Germany
EU/1/99/118/001-004
Date of first authorisation: 02 September 1999
Date of latest renewal: 02 September 2009
Drug | Countries | |
---|---|---|
ARAVA | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.